Galectin-1 Overexpression Activates the FAK/PI3K/AKT/mTOR Pathway and Is Correlated with Upper Urinary Urothelial Carcinoma Progression and Survival

Galectin-1 is a poor prognostic factor in patients with glioblastoma multiforme after radiotherapy

(2018) Shang-Yu Chou et al.   BMC CANCER

Proteomic Identification of the Galectin-1-Involved Molecular Pathways in Urinary Bladder Urothelial Carcinoma

(2018) Chien-Feng Li et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Characteristics of Upper Urothelial Carcinoma in an Area of Balkan Endemic Nephropathy in South Serbia. A fifty-year Retrospective Study

(2018) Rade Cukuranovic et al.   TUMORI

UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses

(2017) Darshan S. Chandrashekar et al.   NEOPLASIA

shinyGEO: a web-based application for analyzing gene expression omnibus datasets

(2016) Jasmine Dumas et al.   BIOINFORMATICS

Role of galectin-1 in urinary bladder urothelial carcinoma cell invasion through the JNK pathway

(2016) Kun-Hung Shen et al.   CANCER SCIENCE

Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signaling

(2016) P-F Zhang et al.   Cell Death & Disease

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update

(2015) Morgan Rouprêt et al.   EUROPEAN UROLOGY

Galectin-1 Dysregulation Independently Predicts Disease Specific Survival in Bladder Urothelial Carcinoma

(2015) Ting-Feng Wu et al.   JOURNAL OF UROLOGY

Galectin-1, -3 and -9 Expression and Clinical Significance in Squamous Cervical Cancer

(2015) Simone Punt et al.   PLoS One

Galectin Expression Profiling Identifies Galectin-1 and Galectin-9Δ5 as Prognostic Factors in Stage I/II Non-Small Cell Lung Cancer

(2014) Iris A. Schulkens et al.   PLoS One

Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer

(2014) P Zhang et al.   Cell Death & Disease

Galectin-1 serum levels reflect tumor burden and adverse clinical features in classical Hodgkin lymphoma

(2013) J. Ouyang et al.   BLOOD

Galectin-1 Is an Independent Prognostic Factor for Local Recurrence and Survival After Definitive Radiation Therapy for Patients With Squamous Cell Carcinoma of the Uterine Cervix

(2013) Eng-Yen Huang et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Genome-Wide Mutational Signatures of Aristolochic Acid and Its Application as a Screening Tool

(2013) S. L. Poon et al.   Science Translational Medicine

Molecular aspects of upper tract urothelial carcinoma

(2013) Nilay Patel et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Clinicopathological and prognostic significance of galectin-1 and vascular endothelial growth factor expression in gastric cancer

(2013) Jie Chen   WORLD JOURNAL OF GASTROENTEROLOGY

Targeting Galectin-1 Overcomes Breast Cancer-Associated Immunosuppression and Prevents Metastatic Disease

(2012) T. Dalotto-Moreno et al.   CANCER RESEARCH

Galectin-1 Promotes Lung Cancer Progression and Chemoresistance by Upregulating p38 MAPK, ERK, and Cyclooxygenase-2

(2012) L.-Y. Chung et al.   CLINICAL CANCER RESEARCH

Galectin 1 expression is associated with tumor invasion and metastasis in stage IB to IIA cervical cancer

(2012) Ha-Jeong Kim et al.   HUMAN PATHOLOGY

The role of galectins in colorectal cancer progression

(2011) Hannah Barrow et al.   INTERNATIONAL JOURNAL OF CANCER

Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973-2005

(2010) Jay D. Raman et al.   BJU INTERNATIONAL

Significant Predictive Factors for Prognosis of Primary Upper Urinary Tract Cancer after Radical Nephroureterectomy in Taiwanese Patients

(2008) Ching-Chia Li et al.   EUROPEAN UROLOGY

Upper Urinary Tract Urothelial Cell Carcinomas and Other Urological Malignancies Involved in the Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) Tumor Spectrum

(2008) Morgan Rouprêt et al.   EUROPEAN UROLOGY